摘要
目的探讨肺结核患者治疗前后血清降钙素原的变化及其临床意义。方法应用ELISA方法检测24例肺结核患者治疗前后和18例健康人血清中降钙素原的含量。结果治疗前肺结核患者血清中降钙素原的含量显著高于对照组(P<0.01);治疗后肺结核患者血清中降钙素原的含量显著低于治疗前(P<0.01),且与对照组无统计学差异(P>0.05)。结论检测肺结核患者血清中降钙素原的含量可以用于评价疾病的治疗效果。
Objective To investigate the clinical value of serum procalcitonin （PCT） changes in patients with pulmonary tuberculosis before and after the treatment. Methods The study used ELISA method to detect the PCT levels in 24 patients with pulmonary tuberculosis before and after the treatment and 18 healthy people as the control group. Results The level of PCT in patients with pulmonary tuberculosis before the treatment was obviously higher than that in the controls （P 〈0. 01 ）. The content of PCT after the treatment in patients with pulmonary tuberculosis decreased obviously while compared with that before the treatment （P 〈0. 01 ）, and had no statistica/ significance while compared with that in the control group. Conclusion It can be helpful for the evaluation of therapeutic efficacy to detect the content of PCT in patients with pulmonary tuberculosis.
出处
《临床肺科杂志》
2013年第1期99-100,共2页
Journal of Clinical Pulmonary Medicine
关键词
肺结核
降钙素原
治疗
pulmonary tuberculosis
procalcitonin
therapy
